iDNA Genomics Public (CYS:IDNA) ROE % Adjusted to Book Value: 0.00% (As of . 20)


CYS:IDNA iDNA Genomics Public Ltd CYS:IDNA
23 GF Score
Price €22.80
! 2 Warning Signs
View Full Analysis

What is iDNA Genomics Public ROE % Adjusted to Book Value?

iDNA Genomics Public CYS:IDNA 23 ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus rates CYS:IDNA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

iDNA Genomics Public's ROE % for the quarter that ended in . 20 was 0.00%. iDNA Genomics Public's PB Ratio for the quarter that ended in . 20 was N/A. iDNA Genomics Public's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

iDNA Genomics Public ROE % Adjusted to Book Value Related Terms

iDNA Genomics Public ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for iDNA Genomics Public's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iDNA Genomics Public ROE % Adjusted to Book Value Chart

iDNA Genomics Public Annual Data
Trend
ROE % Adjusted to Book Value

iDNA Genomics Public Semi-Annual Data
ROE % Adjusted to Book Value

CYS:IDNA vs : ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, iDNA Genomics Public's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iDNA Genomics Public ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iDNA Genomics Public's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where iDNA Genomics Public's ROE % Adjusted to Book Value falls into.


CYS:IDNA
23GF Score
iDNA Genomics Public Ltd CYS:IDNA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iDNA Genomics Public ROE % Adjusted to Book Value Calculation

iDNA Genomics Public's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

iDNA Genomics Public's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
iDNA Genomics Public (CYS:IDNA) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on iDNA Genomics Public and its competitors.
Is iDNA Genomics Public's ROE % Adjusted to Book Value too high?
iDNA Genomics Public's current ROE % Adjusted to Book Value is 0.00%. Overall, iDNA Genomics Public has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does iDNA Genomics Public's ROE % Adjusted to Book Value compare to ?
iDNA Genomics Public's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on iDNA Genomics Public and its competitors. iDNA Genomics Public's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iDNA Genomics Public stock overvalued right now?
iDNA Genomics Public (CYS:IDNA) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. iDNA Genomics Public's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For iDNA Genomics Public (CYS:IDNA), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iDNA Genomics Public Business Description

Comparable Companies
Address 7 Hatzidaki Street, Trypiotis, Nicosia, CYP, 1066
iDNA Genomics Public Ltd operates in the field of genomics and biotechnology and specializes in personalized health care. Its purpose is to develop and provide genetic tests in the field of genomics, through professionals (Medical Genomics) and directly to the consumer (Direct-to-Consumer Genomics).
23GF Score

Get the complete analysis for CYS:IDNA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price